ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RANDY FUENTES M.D.

Internal Medicine

20,386

$1.04M

857
635 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

VAQAR DAR MD

Internal Medicine

33,587

$1.76M

854
758 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

MARCELO CHAUVET M.D.

Internal Medicine

10,018

$751K

853
657 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

SHYLESH GANTA M.D.

Internal Medicine

20,594

$1.24M

853
766 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

JAYARAM NAIDU MD

Internal Medicine

22,620

$1.32M

852
690 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

NORMAN DAVENPORT MD

Internal Medicine

22,084

$1.34M

851
795 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

IRINA MININA M.D

Internal Medicine

18,231

$1.37M

851
690 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

LAILA HIRJEE M.D.

Internal Medicine

36,791

$2.23M

848
808 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

MSONTHI LEVINE MD

Internal Medicine

15,488

$1.07M

848
561 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

FRANCIS GUMBEL MD PA

Internal Medicine

23,447

$1.26M

844
717 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

CARLOS CASAS M.D.

Internal Medicine

32,277

$2.25M

842
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

ANTONIO RUIZ M.D.

Internal Medicine

37,320

$2.62M

842
458 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

RAYLEEN VILLANUEVA-RUMPF M.D.

Internal Medicine

18,077

$1.02M

841
685 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

RICARDO CUADRA MD

Internal Medicine

18,985

$1.08M

838
625 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

HEINE RUIZ M.D.

Internal Medicine

6,235

$346K

838
686 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

SALIL TREHAN M.D.

Internal Medicine

18,213

$1.08M

837
719 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

NATALIE TOLBERT-BORNSTEIN M.D.

Internal Medicine

8,863

$718K

836
658 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $67

AMAN JAFAR MD

Internal Medicine

26,212

$1.88M

835
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

HENRY GRAINGER DO

Internal Medicine

21,306

$1.51M

834
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

37%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

CHRISTOPHER LOCKHART M.D.

Internal Medicine

34,128

$2.12M

834
700 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

ROBERT VOGEL M.D.

Internal Medicine

27,854

$1.58M

833
714 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

ROGER KISER MD

Internal Medicine

35,952

$2.13M

832
699 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

RONALDO FACTORIZA M.D.

Internal Medicine

23,247

$1.62M

828
716 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

WILLIAM COUCH MD

Internal Medicine

14,918

$795K

825
754 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

ROGER SCHULTZ M.D.

Internal Medicine

12,179

$669K

823
744 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank